SEC Form 4 · accession 0000899243-19-001150
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David F Welch
Director
Period of report
Jan 10, 2019
Accepted (ET)
Jan 14, 2019 · 7:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.50 | Jan 10, 2019 | A | 38,904 | A | — | Jan 10, 2029 | Common Stock | 38,904 | 38,904 | D |
Explanation of responses
- F1The option will vest commencing on March 1, 2019 with respect to 13,904 shares and on June 1, 2019 with respect to 25,000 shares.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney